from TheAge
"
10:20am: The main loser among the top 200 this morning is CSL, which is down about 5 per cent after an Alzheimer's therapy by competitor Baxter failed in late stage trial.
This is seen as a blow for CSL as both the Australian company and Baxter stood to benefit from the potential use of immunoglobulin treatments in Alzheimer's patients.
"
Read more: http://www.theage.com.au/business/markets-live/markets-live-strong-start-for-stocks-20130508-2j6lc.html#ixzz2SekCqnAq
from TheAge "10:20am: The main loser among the top 200 this...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.93 |
Change
0.030(0.01%) |
Mkt cap ! $148.8B | |||
| Open | High | Low | Value | Volume |
| $307.51 | $308.38 | $306.26 | $142.0M | 461.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1829 | $307.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.95 | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |